Clinilabs invites you to their event

Early Drug Development Programs: The Need for Translational Medicine and Proven Regulatory Strategies

September 09, 2020 13:00 (EDT)
About 45 minutes

About this event

Attendees will gain an understanding of:

  • The role of translational medicine in a drug development program
  • The ways in which preparation plays a role in a successful IND package and pre-IND meeting
  • And more! 

Hosted by

  • Team member
    T
    Jeanine Falinski Vice President, Strategy and Corporate Development @ Clinilabs Drug Development Corporation

    Ms. Jeanine Falinski, VP of Strategy and Corporate Development, has more than 20 years of experience in the pharmaceutical industry. Jeanine graduated from Emerson College with a degree in New Media and Marketing, later on receiving her MBA in Pharmaceutical Management from Drexel University.

  • Guest speaker
    G
    Dr. Luana Pesco Koplowitz President and Chief Medical & Scientific Officer @ DUCK FLATS Pharma

    Dr. Pesco Koplowitz works with multiple pharmaceutical and biotechnology companies in the fields of nonclinical development, translational medicine, clinical pharmacology, and regulatory strategy.

Clinilabs

The CRO for CNS

We are a global, full-service contract research organization (CRO), the only one focused exclusively on central nervous system (CNS) drug development. We are dedicated to bringing new therapies to patients living with mental health, neurological and substance abuse disorders.

View all events
Host webinars on Host webinars on Livestorm
Virtual Meetings ∙ Webinars ∙ Virtual Events ∙ On-Demand Webinars ∙ Automated Webinars ∙ Product Demos ∙ Company communication ∙ Customer training ∙ Live Q&As ∙ Employee onboarding ∙ Live events